April 8, 2025 - 09:20

In the wake of escalating trade tensions, Evercore ISI has highlighted a selection of 38 stocks that are poised to outperform the S&P 500 over the next year. As tariffs and trade disputes lead to a significant downturn in the stock market, many investors are feeling the pressure. However, Evercore ISI believes that this downturn has created unique buying opportunities in several sectors.
The firm points out that the current market environment, characterized by lower valuations, may favor these identified stocks as they are deemed undervalued. With a careful analysis of market trends and economic indicators, Evercore ISI suggests that these companies could rebound strongly as the market stabilizes and investor sentiment improves.
This perspective comes at a crucial time when many investors are reevaluating their portfolios in light of the ongoing trade war. The potential for recovery in these stocks could provide a strategic advantage for those looking to capitalize on market fluctuations.
August 2, 2026 - 04:37
Tim Steller’s column: Grant Road businesses fold as construction adds to woesThe long-running reconstruction of Grant Road is pushing some Tucson businesses to the breaking point, adding fresh pressure to shops already struggling with street drug activity and the slow...
August 1, 2026 - 02:39
Taiwanese representatives highlights Taiwan-US business ties and shared democratic valuesA senior Taiwanese representative used a recent forum to spotlight the deepening economic relationship between Taiwan and the United States, framing the partnership as one built on both commercial...
July 31, 2026 - 03:22
Your CRM Isn't Enough — Here's the Relationship Infrastructure Founders Actually Need to ScaleMost founders pour their energy into product development and distribution when scaling, but the true competitive advantage often hides in something far less glamorous: how they manage relationships...
July 30, 2026 - 21:58
Cleerly and Allelica launch a new tool for assessing genetic risk in heart patientsA new diagnostic tool aims to give doctors a clearer picture of a patient`s heart disease risk by combining genetic data with advanced imaging. The test, developed by Cleerly in partnership with...